From the article:
"Whilst significant reductions in pain NRS and KOOS subscales were observed in this study, these were of similar magnitude to changes seen over similar periods in the placebo arm of recent placebo-controlled knee OA pharmacological RCTs. Moreover, it is not a randomised clinical trial (RCT) and there is no control group, the placebo response could be playing an important role in this open-label study."
In short, the oral formulation doesn't work.
From the article: "Whilst significant reductions in pain NRS and...
-
- There are more pages in this discussion • 772 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
24.5¢ |
Change
-0.015(5.77%) |
Mkt cap ! $85.70M | |||
| Open | High | Low | Value | Volume |
| 26.0¢ | 26.0¢ | 24.5¢ | $265.4K | 1.050M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 8 | 130186 | 24.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 25.0¢ | 11571 | 1 |
View Market Depth
| Last trade - 16.10pm 31/07/2024 (20 minute delay) ? |
| PAR (ASX) Chart |